Introduction
MicroRNAs constitute a growing class of non-coding RNAs (1, 2) . Most animal microRNAs are imperfectly complementary to their mRNA targets and inhibit protein synthesis through an unknown mechanism (3). MicroRNAs have been reported to modulate hematopoietic lineage differentiation (4), adipocyte differentiation (5), insulin secretion (6) and HIV-1 transcription (7), thus indicating that they could play important roles in a number of biological processes. The high degree of phylogenetic conservation of pre-microRNA sequences also supports the importance of this biological system (8) .
Dahl salt-sensitive rats (DS) are one of the most prevalently used animal models of salt-sensitive hypertension (9−12) . Although more than 16 quantitative trait loci (QTLs) have been identified in this model (13) , most of the genes responsible for hypertension have not yet been identified (14) . The precise mechanism of the increased salt retention in the kidneys of DS remains to be elucidated (15, 16) .
As described above, the microRNA system has been recognized to play important roles in various biological processes. It is thus possible that irregularities in this microRNA system are involved in the pathogenesis of hypertension in DS. The purpose of the present study was to address this hypothesis.
A microRNA cDNA library was constructed in order to identify the major microRNAs expressed in the kidney. The expression levels of more than 100 microRNA species were then assessed in the kidneys of DS and Lewis rats (LW). Moreover, microRNA expression profiles in the heart, one of the target organs of hypertension, were also investigated. A similar strategy has been employed by Poy et al. (6) . They have identified 67 different microRNAs in the miRNA library No homologous sequences were found in rat miRNA Registry, but identical sequences are present in other organisms (mouse, mmu; C. elegance, cel).
form murine pancreatic β-cell line MIN6 and murine pancreatic α-cell line TC1. And one of them, the islet-specific miR-375 (miR means microRNA), has been found to be involved in insulin secretion (6) .
Methods

Animal Studies
DS and LW rats were obtained from Charles River Laboratories (Yokohama, Japan) and Oriental Yeast, Co., Ltd. (Tokyo, Japan), respectively. Rats were weaned at 4 weeks of age and then fed a 0.2% or 8% NaCl diet (Oriental Yeast, Co., Ltd.) for a period of 9 weeks (14, 17) . We compared the expression levels in DS and LW, since we have previously performed genetic linkage analyses in the F2 rats derived from DS and LW (14) . All rats were killed by cervical dislocation following a brief period of ether anesthesia, and the kidneys and hearts were rapidly removed. Total RNA was extracted from the kidneys and the left ventricles using Trizol reagent (Invitrogen, Carlsbad, USA). The present study was conducted in accordance with current guidelines for the care and use of experimental animals of the National Cardiovascular Center.
Cloning of MicroRNAs
Cloning of microRNAs was essentially performed as described by Lagos-Quintana et al. (18) . Total RNA (500 μg) was separated on a 15% denaturing polyacrylamide gel and RNA fractions of between 18 and 25 bases were selected. A 5′-phosphorylated 3′-adaptor oligonucleotide (5′-pUUUaac cgcgaattccagx: uppercase, RNA; lowercase, DNA; p, phosphate; x, 3′-Amino-Modifier C-7; Integrated DNA Technologies, Inc., Coralville, USA) and a 5′-adaptor oligonucleotide (5′-acggaattcctcactAAA: uppercase, RNA; lowercase, DNA) were directionally ligated to the small RNAs. Adaptor-ligated RNA was amplified by reverse transcription and polymerase chain reaction (RT-PCR) with a 3′-primer (5′-CAGCCAA CAGGCACCGAATTCCTCACTAAA) and a 5′-primer (5′-GACTAGCTTGGTGCCGAATTCGCGGTTAAA). Polymerase chain reaction (PCR) products were then digested with Ban1 and concatamerized using T4 DNA ligase. Concatamers ranging in size from 500 to 1,000 bp were separated on agarose gel and directly ligated in a pCR3.1-TOPO vector. Plasmid inserts were amplified by PCR using primers to vector sequences and were subjected to direct sequencing. Sequences from cloned microRNAs were grouped by sequence identity, and compared with a public database, the microRNA registry (http://www.sanger.ac.uk/Software/ Rfam), in order to identify the clones. Unknown sequences, including sequences homologous to particular microRNAs, were searched using the Basic Local Alignment Sequence Tool (BLAST) algorithm, available at the National Center for Biotechnology Information (NCBI). The flanking sequences of the novel microRNAs were used to predict the secondary structure with the RNAfold program of the Vienna RNA package (http://www.tbi.univie.ac.at/). All of the novel microRNAs were submitted to the microRNA Registry website for official annotation.
Northern Blot Analysis
Fractionated total RNA was transferred to a Zetaprobe membrane (Biorad, Hercules, USA) and cross-linked to the membrane by UV irradiation. The resulting blots were then probed with StarFire probes corresponding to various microRNAs, which were labeled with [α-32 P]dATP. Prehybridization and hybridization were carried out as described previously (8) . Equal amounts of RNA from the five rats in each group were pooled and these samples (10 μg) were used for first screening. We assessed the expression levels in the four groups: DS with high-salt diet (DS+), DS with normal-salt diet (DS-), LW with high-salt diet (LW+), and LW with normal-salt diet (LW-). When there was an apparent difference in expression among the four groups, the expression levels were reassessed with other Northern strips. Since the expression levels of several microRNAs (miR-30c, miR-151*, miR-214, miR-223, miR-322, Can-1, Can-7) were reconfirmed to differ among the four groups, the expression levels of these microRNAs were assessed in individual rats (n= 5).
Results and Discussion
If the microRNA system were involved in the pathogenesis of hypertension, some microRNAs would be differentially expressed in the kidneys of hypertensive and normotensive rats. We initially investigated the microRNAs that were abundantly expressed in rat kidneys by constructing microRNA libraries. Four microRNA libraries were constructed from a DS given a high-salt diet (DS+), a DS given a normal diet (DS-), an LW given a high-salt diet (LW+) and an LW given a normal diet (LW-). About 400 tags for microRNAs were sequenced and identified in each library, as shown in Table 1 .
We identified 84 previously reported microRNA species and 7 microRNAs that have not been reported in rats (mmulet-7g, mmu-miR-15a, cel-miR-83, cel-miR-84, mmu-miR-182, mmu-miR-189, mmu-miR-199a*). We also identified 12 possible microRNA species, designated candidates (Can) 1 to 12 ( Table 2 ). All of these new microRNA sequences were found in the rat genome. The sequences surrounding these potential microRNAs showed a stem-loop structure, which is a prerequisite for microRNA processing. Moreover, expression of these possible microRNAs was confirmed by Northern blotting (Fig. 1) . Some species of microRNA (miR-21, miR-26b, miR-29a, miR-126*) were abundantly expressed (> 5%) in the kidney. The number of tags corresponding to miR-21 in the DS+ rat seemed to be larger than those in the other rats. Although the Northern blot analysis confirmed that the expression level of miR-21 in this DS+ rat was indeed higher than that in the other rats, this was not consistently observed in the other DS+ rats.
We then assessed the expression levels of 118 microRNA species in the kidneys of DS+, DS-, LW+, and LW-by Northern blotting (Fig. 1) . These 118 microRNAs included those present among libraries and microRNAs from the chromosome 1 QTL for blood pressure (miR-193, miR-142-3p, miR-142-5p, miR-150, miR-211, miR-301, miR-330, miR-343, miR-344). This chromosome 1 QTL is the most promi-
Fig. 1. Northern blot analysis of microRNAs in kidneys and hearts of Dahl salt-sesitive (DS) and Lewis rats (LW). Male DS and LW fed a 0.2% (-) or 8% (+)
NaCl diet were sacrificed, and the kidneys and hearts were excised. Total RNA was prepared with TRIzol reagent from excised whole tissues and was electrophoresed, blotted, fixed to membrane and hybridized to StarFire probes for each microRNA, as described in the Methods. A total of 29 microRNAs were undetectable in either the kidney or heart (data not shown). These were miR -9, 17-3p, 20, 30a-3p, 31, 32, 33, 34b, 96, 103, 126*, 135a, 135b, 182, 185, 189, 190, 194, 199b, 203, 221, 224, 324-3p, 328, 331, 345 and 351, and cel-miR-83 nent QTL for blood pressure and 2−3 responsible genes are thought to be present in this region (14) . To investigate whether microRNA genes in this region might contribute to blood pressure regulation, we measured the expression levels of the microRNAs in this region. Expression of 76 microRNA species was detected in the kidney (Fig. 1) . Some microRNA species appeared differentially expressed among the four groups, and the expression levels of these microRNA species were subjected to reconfirmation using other Northern blotting strips. Moreover, the expression levels of several microRNA species (miR-30c, miR-151*, miR-214, miR-223, miR-322, Can-1, Can-7) were assessed in individual rats (n= 5). None of the microRNA species were found to be differentially expressed among the kidneys of DS+, DS-, LW+ and LW-. No significant differences in microRNA expression profiles were detected between the strains. Moreover, salt loading did not modulate microRNA expression.
Blood pressure levels of DS+, DS-, LW+ and LW-are shown in Table 3 . Salt loading significantly increased blood pressure in DS+ rats, and the ventricles of DS+ rats were significantly hypertrophied (19−21) .
Although the kidneys of DS+ rats exhibited sclerotic changes, as previously reported (22) , the expression profiles of microRNAs were not markedly altered. Expression profiles of microRNAs have been reported to change dramatically during cellular differentiation (23−25) and in cancer cell growth (26, 27) , and it is likely that the expression profiles of microRNAs are not modulated without cellular differentiation.
We then investigated the expression profiles of microRNAs in the ventricles of the heart. The left ventricle of the heart is one of the target organs most affected by high blood pressure (28) , and significant cardiac hypertrophy was observed in the DS+ rat (Table 3) . It is well known that hypertrophy dramatically changes the expression profiles of mRNA from an adult to a fetal pattern (29, 30) . Although we did not construct libraries from the ventricles of the heart and heart-specific microRNAs may not be involved in the analysis, no significant differences in microRNA expression profiles were observed among the four groups, despite the marked cardiac hypertrophy in the DS+ (Fig. 1) . This observation also strengthens the hypothesis that microRNA expression profiles are specific to each cell type, and may not be modulated without cellular differentiation.
The precise number of microRNAs has not been determined (31, 32) . Moreover, we were not able to detect microRNAs with low expression levels. The kidney comprises a variety of cells. Thus, some species of cell-specific microRNA may have been diluted to an undetectable level in total RNA derived from the whole kidney. Therefore, it may be premature to conclude that microRNA systems are not involved in the pathogenesis of hypertension in DS.
There were several limitations in the present study. We employed Northern blot analysis for the assessment of the expression levels. Although we used a StarFire oligo labeling method (Integrated DNA Technologies) that permits the generation of oligonucleotide probes which are 10-fold more sensitive than traditional 32 P end-labeled probes, the sensitivity of the Northern blot may not have been sufficiently high, in which case a substantial number of microRNAs would not have been detected in the present study. This limitation is currently being overcome by various experimental procedures, including a microarray system, a TaqMan probe-based realtime PCR method, and an RNase mapping method. Future investigation will require application of these methods. Dahl salt-sensitive (DS) and Lewis rats (LW) were fed a 0.2% (-) or 8% (+) NaCl diet from 4 to 13 weeks of age. *p< 0.01, DS(+) compared to each other group (n=5). BW, body weight; HW, heart weight; SBP, systolic blood pressure.
